Antigen
An antigen is a molecule, molecular structure, or molecular fragment that can be specifically recognized by components of the immune system, including antibodies, immunoglobulin M, B-cell receptors, and T-cell receptors.
An antigen is a molecule, molecular structure, or molecular fragment that can be specifically recognized by components of the immune system, including antibodies, immunoglobulin M, B-cell receptors, and T-cell receptors. The regions recognized by these receptors are called epitopes. Antigens may originate from infectious organisms, tumors, or other external or altered biological sources. Their recognition can contribute to humoral immunity, cell-mediated immunity, cytokine production, and broader immune responses, although antigen recognition does not necessarily produce protective immunity on its own.
In biomedical research, antigens are central to vaccine development, immune diagnostics, and targeted delivery. Current vaccine-technology studies address antigen selection through approaches such as reverse vaccinology, antigen stability testing, and structure-guided analysis, while delivery systems including mRNA-lipid nanoparticles, adenoviral vectors, nanocarriers, and antigen-presenting-cell targeting are being investigated to improve immunogenicity and tissue-specific immune modulation. Antigen-producing muscle cells, pulmonary delivery, and tissue-resident memory T-cell responses are among the biological contexts examined in these studies. Antigens are also being modeled in complexes with nanobodies, detected in human serum using biomaterial platforms, and evaluated as candidates against pathogens such as Salmonella Typhi, Chlamydia pecorum, syphilis-associated Treponema pallidum, and respiratory infectious agents.
Where the papers sit
9 papers from the last 6 months study antigen directly · updated from PubMed 17 Nov 2026
Study type 0 clinical trials · 2 human data · 7 preclinical
Themes one subject
Those 9 are all about one subject.
-
Vaccine Technology Development
Vaccine design is expanding from antigen selection toward stability, structure-guided engineering, targeted delivery, and tissue-specific immune programming. Nanocarriers, mRNA-LNPs, adenoviral vectors, and APC targeting recur as routes to improve immunogenicity and delivery. Pathogen genomics and MOMP stability support antigen selection and deployable formulations, while biomolecule-detection platforms aid measurement. The work remains exploratory, with no single platform or disease dominating.
Papers
The 9 papers from the last 6 months that study antigen directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Vaccine Technology Development (9)
- A Multiformat Alginate Hydrogel Platform for Persistent Luminescence-Based Biomolecule Detection in Human Serum. ACS applied bio materials · 6 Nov 2026 PMID 42993017
- Combining AI Structure Prediction and Integrative Modeling for Nanobody-Antigen Complexes. Journal of chemical information and modeling · 14 Sept 2026 PMID 42734515
- Phenylborate-Functionalized Nanocarriers Enable Lung-Tropic Protein Delivery and Reprogramming of Tissue-Resident Immunity. ACS nano · 8 Sept 2026 PMID 42708904
- Integrated genomic analysis of Salmonella Typhi from Pakistan: Antimicrobial resistance determinants, pangenome structure, and reverse vaccinology-driven vaccine target discovery. Functional & integrative genomics · 19 Aug 2026 PMID 42616173
- Stability of Chlamydia pecorum MOMP at 37 °C: suitability for use in delayed-release vaccine implants in koalas (Phascolarctos cinereus). Vaccine · 4 Aug 2026 PMID 42551398
- Advancements in Syphilis Vaccine Development. Sexually transmitted diseases · 1 Jul 2026 PMID 42383911
- Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery and efficacy. Journal of controlled release : official journal of the Controlled Release Society · 30 Jun 2026 PMID 42379311
- Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines. Molecular therapy : the journal of the American Society of Gene Therapy · 27 Jun 2026 PMID 42363600
- Nanotechnology-Enhanced Vaccines for Respiratory Infections: Opportunities and Challenges. International journal of nanomedicine · 18 Jun 2026 PMID 42311421
By study type
Human data, design not indexed (2)
- A Multiformat Alginate Hydrogel Platform for Persistent Luminescence-Based Biomolecule Detection in Human Serum. ACS applied bio materials · 6 Nov 2026 PMID 42993017
- Integrated genomic analysis of Salmonella Typhi from Pakistan: Antimicrobial resistance determinants, pangenome structure, and reverse vaccinology-driven vaccine target discovery. Functional & integrative genomics · 19 Aug 2026 PMID 42616173
Preclinical: animal, cell and lab studies (7)
- Combining AI Structure Prediction and Integrative Modeling for Nanobody-Antigen Complexes. Journal of chemical information and modeling · 14 Sept 2026 PMID 42734515
- Phenylborate-Functionalized Nanocarriers Enable Lung-Tropic Protein Delivery and Reprogramming of Tissue-Resident Immunity. ACS nano · 8 Sept 2026 PMID 42708904
- Stability of Chlamydia pecorum MOMP at 37 °C: suitability for use in delayed-release vaccine implants in koalas (Phascolarctos cinereus). Vaccine · 4 Aug 2026 PMID 42551398
- Advancements in Syphilis Vaccine Development. Sexually transmitted diseases · 1 Jul 2026 PMID 42383911
- Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery and efficacy. Journal of controlled release : official journal of the Controlled Release Society · 30 Jun 2026 PMID 42379311
- Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines. Molecular therapy : the journal of the American Society of Gene Therapy · 27 Jun 2026 PMID 42363600
- Nanotechnology-Enhanced Vaccines for Respiratory Infections: Opportunities and Challenges. International journal of nanomedicine · 18 Jun 2026 PMID 42311421
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-11-17. Drafted by language models from published abstracts; not medical advice.